Event Highlights
MANAGING TYPE 2 INFLAMMATION IN SEVERE ASTHMA

Asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) are often said to be analogous to siblings, given their overlapping pathophysiology and inflammation pathways. On 13 th December 2023, it was privileged to have invited Dr. Terence Tam Chi...

Feb 7, 2024
Biologic for managing atopic dermatitis: further u[dates for younger children Scientific Metting for Paediatrics Department of P

Atopic dermatitis (AD), one of the most common skin conditions worldwide, has shown an increasing severity and chronicity in recent years, affecting 20.6% of children and adolescents. Fortunately, recent advancements in the management of AD have rek...

Feb 7, 2024
Advancement in AML treatment

The treatment landscape of acute myeloid leukaemia (AML) is constantly evolving, and a new form of treatment for AML, oral azacitidine, has just become available in Hong Kong. On 18 th January 2024, the Hong Kong Society of Haematology organised a s...

Feb 7, 2024
Unveiling the 2023 ESH Hypertension Guidelines and its Practical Implications

The European Society of Hypertension (ESH) presented the updated guidelines for hypertension management in 2023 Summer. Coincidently, 2023 marks the 10 th anniversary of the launch of nebivolol in Hong Kong. To celebrate these milestones, A. Menarin...

Dec 18, 2023
11th Annual General Meeting cum Hybrid Seminar

On 21 st October 2023, The Hong Kong Respiratory Nursing College (HKRNC) held the 11 th Annual General Meeting in Cordis Hotel, Mong Kok, which came with a hybrid seminar to discuss the management of asthma. The event was opened with the President o...

Dec 18, 2023
APHRS 2023 Hong Kong

The recently concluded 16th Asia Pacific Heart Rhythm Society (APHRS) Scientific Session, held in conjunction with CardioRhythm 2023, took place in Hong Kong from 1st to 3rd September 2023. Organised by the APHRS and the Hong Kong College of Cardiol...

Oct 26, 2023
Endless Love Spring Memorial Ceremony 2023

Organ transplant is crucial to individuals suffering from organ failure for various reasons, including chronic illnesses, accidents, autoimmunity, and genetic disorders. Constrained by traditional values, religious reasons and a low social awareness...

Aug 11, 2023
Hybrid Symposium on Managing Multiple Myeloma Insight on Multiple Myeloma

Multiple Myeloma (MM) is a haematological malignancy characterised by the uncontrolled proliferation of mutated plasma cells in the bone marrow. In Hong Kong, there are about 300 new cases per year. Very often, patients with MM are presented with an...

Aug 11, 2023
Celebrating the 25th Anniversary of Automated Peritoneal Dialysis Program in Hong Kong

End-stage renal disease (ESRD), a common condition among patients with diabetes or high blood pressure, is characterised by malnutrition, neuropathy, dry skin, nausea, and anaemia, often leading to reduced quality of life and premature mortality. As...

Jun 13, 2023
Clinical Applications of Tumour-Treating Fields in Glioblastoma

Glioblastoma is the most common and aggressive primary brain tumour. While glioblastoma can occur at any age, it tends to occur more often in older adults. The disease course is typically rapid, with only approximately 1 in 4 patients alive 2 years ...

Dec 22, 2022
Updates on XEN Gel Stent Implantation and Fixed-dose Combination Eye Drops

Ocular surface disease (OSD) is a multifactorial disease of the ocular surface that results in symptomatic discomfort, visual disturbances, and tear film instability with progressive histopathologic and clinical changes to the ocular surface. OSD is...

Dec 22, 2022
Optimising Treatment Outcomes of RET Fusion-positive NSCLC

Non-small cell lung cancer (NSCLC) is one of the leading causes of death globally. In recent years, the identification of multiple molecular alterations in NSCLC has led to the development of target-based therapies, which have shown significant clin...

Dec 22, 2022